Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Van Der Graaf, Anne Marijn ^a   Wiegman, Marjon J ^a   Plösch, Torsten ^a   Zeeman, Gerda G ^a   Van Buiten, Azuwerus ^a   Henning, Robert H ^a   Buikema, Hendrik ^a   Faas, Marijke M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LOSARTAN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PLACEBO; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT RELAXATION; FEMALE; HYPERPOLARIZATION; ISOLATED ORGAN; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; IMIDAZOLES; LIPOPOLYSACCHARIDES; LOSARTAN; NITRIC OXIDE SYNTHASE TYPE II; PRE-ECLAMPSIA; PREGNANCY; PROSTAGLANDINS; PYRIDINES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; VASODILATOR AGENTS;

EID: 84892400952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079884     Document Type: Article

References (85)

1. Steegers EA, von DP, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376: 631-644. doi:10.1016/S0140-6736(10)60279-6. PubMed: 20598363.
2. Li C, Ansari R, Yu Z, Shah D (2000) Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 36: 159-164. doi:10.1161/01.HYP.36.2.159. PubMed: 10948071.
3. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van AA (1994) A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101: 669-674. doi:10.1111/j.1471-0528.1994.tb13182.x. PubMed: 7947500.
4. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y (2007) The role of the immune system in preeclampsia. Mol Aspects Med 28: 192-209. doi:10.1016/j.mam.2007.02.006. PubMed: 17433431.
5. Roberts JM, Redman CW (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451. doi: 10.1016/0140-6736(93)90889-O. PubMed: 8099148.
6. Nielsen AH, Schauser KH, Poulsen K (2000) Current topic: the uteroplacental renin-angiotensin system. Placenta 21: 468-477. doi: 10.1053/plac.2000.0535. PubMed: 10940196.
7. Cockell AP, Poston L (1997) Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30: 247-251. doi:10.1161/01.HYP.30.2.247. PubMed: 9260988.
8. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP (1990) Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 76: 1061-1069. PubMed: 2234714.
9. Cockell AP, Poston L (1996) Isolated mesenteric arteries from pregnant rats show enhanced flow-mediated relaxation but normal myogenic tone. J Physiol 495 (2): 545-551. PubMed: 8887764.
10. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB et al. (2009) Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 7: 79. doi:10.1186/1477-7827-7-79. PubMed: 19646248.
11. Delemarre FM, Thomas CM, van den Berg RJ, Jongsma HW, Steegers EA (2000) Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction. Prostaglandins Leukot Essent Fatty Acids 63: 209-215. doi:10.1054/plef.2000.0211. PubMed: 11049696.
12. Lopez-Jaramillo P, Arenas WD, Garcia RG, Rincon MY, Lopez M (2008) The role of the L-arginine-nitric oxide pathway in preeclampsia. Ther Adv. Cardiovasc Dis 2: 261-275.
13. Gillham JC, Kenny LC, Baker PN (2003) An overview of endothelium-derived hyperpolarising factor (EDHF) in normal and compromised pregnancies. Eur J Obstet Gynecol Reprod Biol 109: 2-7. doi:10.1016/S0301-2115(03)00044-7. PubMed: 12818435.
14. Friedman SA (1988) Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 71: 122-137. PubMed: 3275908.
15. Luksha L, Nisell H, Luksha N, Kublickas M, Hultenby K et al. (2008) Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites. Am J Physiol Regul Integr Comp Physiol 294: R510-R519. PubMed: 18032472.
16. Benjamin N, Rymer J, Todd SD, Thom M, Ritter JM (1991) Sensitivity to angiotensin II of forearm resistance vessels in pregnancy. Br J Clin Pharmacol 32: 523-525. doi:10.1111/j.1365-2125.1991.tb03944.x. PubMed: 1958452.
17. Irani RA, Xia Y (2008) The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 29: 763-771. doi: 10.1016/j.placenta.2008.06.011. PubMed: 18687466.
18. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC (1973) A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52: 2682-2689. doi:10.1172/JCI107462. PubMed: 4355997.
19. Brown MA, Wang J, Whitworth JA (1997) The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens 19: 713-726. doi:10.3109/ 10641969709083181. PubMed: 9247750.
20. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721-39726. doi:10.1074/jbc.M105253200. PubMed: 11507095.
21. Doering TP, Haller NA, Montgomery MA, Freeman EJ, Hopkins MP (1998) The role of AT1 angiotensin receptor activation in the pathogenesis of preeclampsia. Am J Obstet Gynecol 178: 1307-1312. doi:10.1016/S0002-9378(98)70337-0. PubMed: 9662316.
22. Saito T, Ishida J, Takimoto-Ohnishi E, Takamine S, Shimizu T et al. (2004) An essential role for angiotensin II type 1a receptor in pregnancy-associated hypertension with intrauterine growth retardation. FASEB J 18: 388-390. PubMed: 14688210.
23. Serreau R, Luton D, Macher MA, Delezoide AL, Garel C et al. (2005) Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases. BJOG 112: 710-712. doi:10.1111/j.1471- 0528.2004.00525.x. PubMed: 15924524.
24. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW (1994) A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171: 158-164. doi: 10.1016/0002-9378(94) 90463-4. PubMed: 8030692.
25. Faas MM, Broekema M, Moes H, van der SG, Heineman MJ, de VP (2004) Altered monocyte function in experimental preeclampsia in the rat. Am J Obstet Gynecol 191: 1192-1198. doi:10.1016/j.ajog. 2004.03.041. PubMed: 15507940.
26. Faas MM, Schuiling GA, Linton EA, Sargent IL, Redman CW (2000) Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol 182: 351-357. doi:10.1016/S0002-9378(00)70223-7. PubMed: 10694336.
27. Faas MM, Schuiling GA, Baller JF, Valkhof N, Bakker WW (1997) Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects. J Lab Clin Med 130: 496-508. doi:10.1016/S0022- 2143(97)90126-8. PubMed: 9390637.
28. Wang Z, Zou H, Yu Y, Song Y (2011) Monoclonal antibody to intercellular adhesion molecule-1 as a novel therapy for preeclampsia: preliminary results from a rat model. J Matern Fetal Neonatal Med, 25: 855-9. PubMed: 21830843.
29. Faas MM, Bakker WW, Valkhof N, Schuiling GA (1999) Effect of estradiol and progesterone on the low-dose endotoxin-induced glomerular inflammatory response of the female rat. Am J Reprod Immunol 41: 224-231. doi:10.1111/j.1600-0897.1999.tb00536.x. PubMed: 10326626.
30. Faas MM, Schuiling GA, Baller JF, Bakker WW (1995) Glomerular inflammation in pregnant rats after infusion of low dose endotoxin. An immunohistological study in experimental pre-eclampsia. Am J Pathol 147: 1510-1518. PubMed: 7485413.
31. Faas MM, Slot K, Koiter TR, Schuiling GA (2000) Corticosterone treatment of pregnant low dose endotoxin-treated rats: inhibition of the inflammatory response. Am J Reprod Immunol 44: 178-183. doi: 10.1111/j.8755-8920.2000.440308. x. PubMed: 11028905.
32. Buikema H, Monnink SH, Tio RA, Crijns HJ, de ZD et al. (2000) Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol 130: 1999-2007. doi:10.1038/sj.bjp.0703498. PubMed: 10952693.
33. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H et al. (1996) The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 17: 787-794. doi:10.1093/oxfordjournals.eurheartj.a014947. PubMed: 8737111.
34. Knock GA, Sullivan MH, McCarthy A, Elder MG, Polak JM et al. (1994) Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 271: 1007-1015. PubMed: 7965763.
35. Oosterga M, Voors AA, Buikema H, Pinto YM, Haber HE et al. (2000) Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovasc Drugs Ther 14: 55-60. doi:10.1023/A:1007843205311. PubMed: 10755201.
36. Ulu N, Buikema H, van Gilst WH, Navis G (2008) Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis. Nephrol Dial Transplant 23: 1854-1860. doi:10.1093/ndt/gfm911. PubMed: 18218687.
37. Voors AA, van Geel PP, Buikema H, Oosterga M, van Veldhuisen DJ et al. (2005) High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries. J Renin Angiotensin Aldosterone Syst 6: 145-150. doi:10.3317/jraas.2005.021. PubMed: 16525945.
38. Stennett AK, Qiao X, Falone AE, Koledova VV, Khalil RA (2009) Increased vascular angiotensin type 2 receptor expression and NOSmediated mechanisms of vascular relaxation in pregnant rats. Am J Physiol Heart Circ Physiol 296: H745-H755. doi:10.1152/ajpheart.00861.2008. PubMed: 19151255.
39. Plösch T, Gellhaus A, van Straten EM, Wolf N, Huijkman NC et al. (2010) The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia? Placenta 31: 910-918. doi:10.1016/j.placenta.2010.07.009. PubMed: 20709391.
40. Buikema H, van Gilst WH, van Veldhuisen DJ, de Smet BJ, Scholtens E et al. (1993) Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovasc Res 27: 2118-2124. doi:10.1093/cvr/27.12.2118. PubMed: 8313417.
41. Aloamaka CP, Ezimokhai M, Cherian T, Morrison J (1993) Mechanism of pregnancy-induced attenuation of contraction to phenylephrine in rat aorta. Exp Physiol 78: 403-410. PubMed: 8329210.
42. Takiuti NH, Carvalho MH, Kahhale S, Nigro D, Barbeiro HV et al. (1999) The effect of chronic nitric oxide inhibition on vascular reactivity and blood pressure in pregnant rats. Sao Paulo Med J 117: 197-204. PubMed: 10592132.
43. Martinez-Org Gonzalez R, Tovar S, Marin J, Salaices M et al. (2003) Administration of N(omega)-L-arginine methyl ester (L-NAME) impairs endothelium-dependent relaxation in gravid but not nongravid rats. J Soc Gynecol Invest 10: 74-81. doi:10.1016/S1071-5576(02)00220-4.
44. Ballejo G, Barbosa TA, Coelho EB, Antoniali C, Salgado MC (2002) Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses. Life Sci 70: 3131-3142. doi:10.1016/S0024-3205(02)01576-X. PubMed: 12008096.
45. St-Louis J, Sicotte B (1992) Prostaglandin- or endothelium-mediated vasodilation is not involved in the blunted responses of blood vessels to vasoconstrictors in pregnant rats. Am J Obstet Gynecol 166: 684-692. doi:10.1016/0002-9378(92)91698-A. PubMed: 1536253.
46. Bobadilla RA, Valencia-Hernández I, Pérez-Alvarez VM, Mera-Jiménez E, Castillo-Henkel C (2001) Changes in vascular reactivity following subrenal aortic constriction in pregnant and nonpregnant rats. Hypertens Pregnancy 20: 143-156. doi:10.1081/PRG-100106964. PubMed: 12044325.
47. Ralevic V, Burnstock G (1996) Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins. Br J Pharmacol 117: 1463-1470. doi:10.1111/j.1476-5381.1996.tb15307.x. PubMed: 8730740.
48. van Drongelen J, Hooijmans CR, Lotgering FK, Smits P, Spaanderman MEvan DJ, Hooijmans CR, Lotgering FK, Smits P, Spaanderman ME (2012) Adaptive changes of mesenteric arteries in pregnancy: a meta-analysis. Am J Physiol Heart Circ Physiol 303: H639-H657. doi: 10.1152/ajpheart.00617.2011. PubMed: 22821990.
49. Davis JR, Giardina JB, Green GM, Alexander BT, Granger JP et al. (2002) Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 282: R390-R399. PubMed: 11792648.
50. Orshal JM, Khalil RA (2004) Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats. Hypertension 43: 434-444. doi:10.1161/01.HYP.0000113044.46326.98. PubMed: 14707155.
51. Goetz RM, Morano I, Calovini T, Studer R, Holtz J (1994) Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 205: 905-910. doi: 10.1006/bbrc.1994. 2750. PubMed: 7528018.
52. Bobadilla RA, Henkel CC, Henkel EC, Escalante B, Hong E (1997) Possible involvement of endothelium-derived hyperpolarizing factor in vascular responses of abdominal aorta from pregnant rats. Hypertension 30: 596-602. doi:10.1161/01.HYP.30.3.596. PubMed: 9322988.
53. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG et al. (1993) Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7: 566-571. PubMed: 7682524.
54. Nathan L, Cuevas J, Chaudhuri G (1995) The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 114: 955-960. doi:10.1111/j.1476-5381.1995.tb13297.x. PubMed: 7780650.
55. Xu Y, Henning RH, van der Want JJ, van BA, van Gilst WH et al. (2007) Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds. Life Sci 80: 1678-1685. doi:10.1016/j.lfs.2007.01.041. PubMed: 17335855.
56. Bobadilla LR, Pérez-Alvarez V, Bracho Valdés I, López-Sanchez P (2005) Effect of pregnancy on the roles of nitric oxide and prostaglandins in 5-hydroxytryptamine-induced contractions in rat isolated thoracic and abdominal aorta. Clin Exp Pharmacol Physiol 32: 202-209. doi:10.1111/j.1440-1681.2005.04172.x. PubMed: 15743404.
57. Aloamaka CP, Ezimokhai M, Morrison J (1993) The role of endothelium in phenylephrine- and potassium-induced contractions of the rat aorta during pregnancy. Res Exp Med (Berl) 193: 407-417. doi:10.1007/BF02576249. PubMed: 8122046.
58. Gant NF, Whalley PJ, Everett RB, Worley RJ, MacDonald PC (1987) Control of vascular reactivity in pregnancy. Am J Kidney Dis 9: 303-307. PubMed: 3555002.
59. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ et al. (1999) Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 282: 356-362. doi:10.1001/jama.282.4.356. PubMed: 10432033.
60. van der Weiden RM, Helmerhorst FM, Keirse MJ (1996) Prostanoid excretion in incipient singleton and twin pregnancies. Am J Obstet Gynecol 174: 1614-1617. doi:10.1016/S0002-9378(96)70616-6. PubMed: 9065139.
61. Vainio M, Riutta A, Koivisto AM, Mäenpää J (2004) Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. Acta Obstet Gynecol Scand 83: 1119-1123. doi:10.1080/j.0001-6349.2004.00396.x. PubMed: 15548142.
62. Malatyalioǧlu E, Adam B, Yanik FF, Kökçü A, Alvur M (2000) Levels of stable metabolites of prostacyclin and thromboxane A2 and their ratio in normotensive and preeclamptic pregnant women during the antepartum and postpartum periods. J Matern Fetal Med 9: 173-177. doi:10.3109/14767050009020524. PubMed: 10914626.
63. Jaspers WJ, De Jong PA, Mulder AW (1981) Angiotensin-II sensitivity and prostaglandin-synthetase inhibition in pregnancy. Eur J Obstet Gynecol Reprod Biol 11: 379-384. doi:10.1016/0028-2243(81)90087-3. PubMed: 6788618.
64. Lewis DF, Canzoneri BJ, Gu Y, Zhao S, Wang Y (2010) Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Am J Reprod Immunol 64: 376-383. doi: 10.1111/j.1600-0897.2010. 00861.x. PubMed: 20482519.
65. Schaefer WR, Seufert RJ, Casper FW, Zahradnik HP (1996) Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. Prostaglandins 52: 1-11. doi: 10.1016/0090-6980(96)00049-4. PubMed: 8875634.
66. Schafer W, Tielsch J, Casper FW, Seufert RJ, Zahradnik HP (1993) Urinary excretion of 6-keto-PGF1 alpha TxB2 and PGE2 in a rat animal model for preeclampsia-like syndrome. Prostaglandins 46: 167-175. doi:10.1016/0090- 6980(93)90042-6. PubMed: 8210446.
67. Mustafa AK, Sikka G, Gazi SK, Steppan J, Jung SM et al. (2011) Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: 1259-1268. doi: 10.1161/CIRCRESAHA.111.240242. PubMed: 21980127.
68. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH (1998) K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272. doi:10.1038/24388. PubMed: 9834033.
69. Gerber RT, Anwar MA, Poston L (1998) Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br J Pharmacol 125: 455-460. doi:10.1038/sj.bjp.0702099. PubMed: 9806327.
70. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR (2002) Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci (Lond) 103: 67-73. doi:10.1042/CS20010354. PubMed: 12095405.
71. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R et al. (1996) The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711. doi: 10.1097/00005344-199611000-00014. PubMed: 8945685.
72. Chu ZM, Beilin LJ (1993) Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. Br J Pharmacol 109: 322-329. doi:10.1111/j.1476-5381.1993.tb13573.x. PubMed: 8358537.
73. Lubarsky SL, Ahokas RA, Friedman SA, Sibai BM (1997) The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat. Am J Obstet Gynecol 176: 1069-1076. doi:10.1016/S0002-9378(97)70404-6. PubMed: 9166170.
74. Anderson CM, Lopez F, Zhang HY, Shirasawa Y, Pavlish K et al. (2006) Mesenteric vascular responsiveness in a rat model of pregnancy-induced hypertension. Exp Biol Med (Maywood) 231: 1398-1402.
75. Cosentino F, Savoia C, De PP, Francia P, Russo A et al. (2005) Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 18: 493-499. doi:10.1016/j.amjhyper.2004.11.007. PubMed: 15831358.
76. Leung PS, Tsai SJ, Wallukat G, Leung TN, Lau TK (2001) The upregulation of angiotensin II receptor AT(1) in human preeclamptic placenta. Mol Cell Endocrinol 184: 95-102. doi:10.1016/S0303-7207(01)00637-2. PubMed: 11694345.
77. Laskowska M, Vinson GP, Szumiło J, Laskowska K, Leszczyñska-Gorzelak B et al. (2003) Comparative analysis of the angiotensin-II receptor in placental vascular endothelial cells in preeclamptic and normotensive patients. Gynecol Obstet Invest 56: 55-60. doi: 10.1159/000072704. PubMed: 12897464.
78. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J et al. (2009) The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology 150: 4316-4325. doi: 10.1210/en.2009-0076. PubMed: 19520788.
79. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281: H2337-H2365. PubMed: 11709400.
80. Wang X, Trottier G, Loutzenhiser R (2003) Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF. Am J Physiol Renal Physiol 285: F540-F549. PubMed: 12734100.
81. Schmitt M, Avolio A, Qasem A, McEniery CM, Butlin M et al. (2005) Basal NO locally modulates human iliac artery function in vivo. Hypertension 46: 227-231. doi:10.1161/01.HYP.0000164581.39811.bd. PubMed: 15867142.
82. Wilkinson IB, Franklin SS, Cockcroft JR (2004) Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 44: 112-116. doi:10.1161/01.HYP.0000138068.03893.40. PubMed: 15262901.
83. Fraga-Silva RA, Ferreira AJ, Dos Santos RA (2012) Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension. Curr Hypertens Rep, 15: 31-8. PubMed: 23212695.
84. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ et al. (1989) Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142: 144-147. PubMed: 2783321.
85. Kvietys PR, Granger DN (2012) Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med 52: 556-592. doi:10.1016/j.freeradbiomed.2011.11.002. PubMed: 22154653.